title: Are IL-10+ regulatory Th17 cells implicated in the sustained response to glucocorticoid treatment in patients with giant cell arteritis? Comment on the paper of Espigol-Frigole et al.
authors.forename: Maxime
authors.initials: M
authors.lastname: Samson
authors.forename: Sylvain
authors.initials: S
authors.lastname: Audia
authors.forename: Nona
authors.initials: N
authors.lastname: Janikashvili
authors.forename: Bernard
authors.initials: B
authors.lastname: Bonnotte
mesh_terms: D001706:Biopsy; D051858:Forkhead Transcription Factors / Q000276:immunology; D013700:Giant Cell Arteritis / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D016753:Interleukin-10 / Q000097:blood / Q000276:immunology*; D020381:Interleukin-17 / Q000096:biosynthesis / Q000276:immunology*; D012008:Recurrence; D013699:Temporal Arteries / Q000276:immunology* / Q000473:pathology; D058504:Th17 Cells / Q000276:immunology*
chemical_list: C418974:FOXP3 protein, human; D051858:Forkhead Transcription Factors; D005938:Glucocorticoids; D020381:Interleukin-17; D016753:Interleukin-10